Paul Piehowski
Overview
Explore the profile of Paul Piehowski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
326
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kelliher J, Xu Y, Flynn M, Babinski M, Canon S, Cavanna E, et al.
Comput Struct Biotechnol J
. 2025 Feb;
23:3575-3583.
PMID: 39963423
Accessible and easy-to-use standardized bioinformatics workflows are necessary to advance microbiome research from observational studies to large-scale, data-driven approaches. Standardized multi-omics data enables comparative studies, data reuse, and applications of...
2.
Pino M, Dijkstra P, Whytock K, Ahn C, Yu G, Sanford J, et al.
Am J Physiol Endocrinol Metab
. 2025 Feb;
328(3):E478-E492.
PMID: 39933702
White adipose tissue (WAT) plays a significant role in whole body energy homeostasis, and its excess typifies obesity. In addition to WAT quantity, perturbations in the basic cellular processes of...
3.
Modak R, de Oliveira Rebola K, McClatchy J, Mohammadhosseini M, Damnernsawad A, Kurtz S, et al.
Clin Cancer Res
. 2024 Mar;
30(10):2245-2259.
PMID: 38451486
Purpose: Emerging evidence underscores the critical role of extrinsic factors within the microenvironment in protecting leukemia cells from therapeutic interventions, driving disease progression, and promoting drug resistance in acute myeloid...
4.
Joshi S, Piehowski P, Liu T, Gosline S, McDermott J, Druker B, et al.
Annu Rev Pharmacol Toxicol
. 2023 Sep;
64:455-479.
PMID: 37738504
Proteogenomics refers to the integration of comprehensive genomic, transcriptomic, and proteomic measurements from the same samples with the goal of fully understanding the regulatory processes converting genotypes to phenotypes, often...
5.
Gosline S, Tognon C, Nestor M, Joshi S, Modak R, Damnernsawad A, et al.
Clin Proteomics
. 2022 Jul;
19(1):30.
PMID: 35896960
Acute Myeloid Leukemia (AML) affects 20,000 patients in the US annually with a five-year survival rate of approximately 25%. One reason for the low survival rate is the high prevalence...
6.
Orwoll E, Wiedrick J, Nielson C, Jacobs J, Baker E, Piehowski P, et al.
Aging Cell
. 2020 Oct;
19(11):e13253.
PMID: 33078901
The biological bases of longevity are not well understood, and there are limited biomarkers for the prediction of long life. We used a high-throughput, discovery-based proteomics approach to identify serum...
7.
Nagarajan A, Zhou M, Nguyen A, Liberton M, Kedia K, Shi T, et al.
Biomolecules
. 2019 Aug;
9(8).
PMID: 31426316
Phycobilisomes (PBSs) are large (3-5 megadalton) pigment-protein complexes in cyanobacteria that associate with thylakoid membranes and harvest light primarily for photosystem II. PBSs consist of highly ordered assemblies of pigmented...
8.
Rodland K, Piehowski P, Smith R
Cancer J
. 2018 May;
24(3):121-125.
PMID: 29794536
Breaking down the silos between disciplines to accelerate the pace of cancer research is a key paradigm for the Cancer Moonshot. Molecular analyses of cancer biology have tended to segregate...
9.
Olah M, Patrick E, Villani A, Xu J, White C, Ryan K, et al.
Nat Commun
. 2018 Feb;
9(1):539.
PMID: 29416036
With a rapidly aging global human population, finding a cure for late onset neurodegenerative diseases has become an urgent enterprise. However, these efforts are hindered by the lack of understanding...
10.
Orwoll E, Wiedrick J, Jacobs J, Baker E, Piehowski P, Petyuk V, et al.
Aging Cell
. 2018 Feb;
17(2).
PMID: 29399943
The biological perturbations associated with incident mortality are not well elucidated, and there are limited biomarkers for the prediction of mortality. We used a novel high-throughput proteomics approach to identify...